Elekta (OTCMKTS:EKTAY) Posts Quarterly Earnings Results

Elekta (OTCMKTS:EKTAY) issued its earnings results on Thursday. The company reported $0.09 earnings per share (EPS) for the quarter, Zacks reports. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.72%. The firm had revenue of $433.29 million for the quarter.

Elekta Stock Performance

EKTAY stock opened at $6.69 on Friday. The stock’s 50 day simple moving average is $6.30 and its 200 day simple moving average is $5.59. The company has a current ratio of 1.04, a quick ratio of 0.79 and a debt-to-equity ratio of 0.66. Elekta has a 12-month low of $4.35 and a 12-month high of $6.93. The stock has a market capitalization of $2.47 billion, a PE ratio of -668.43 and a beta of 1.07.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.